Physician profile
Stephen Glatz
NPI 1649322314
$13,533.24
in general payments reported to CMS, 2019-2025
15 companies · $76.87 in 2025
The $76.87 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $37.81 · 2020: $12.29 · 2021: $11K · 2022: $959 · 2023: $1,250 · 2024: $43.62 · 2025: $76.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $728 · Food and Beverage: $643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $727.88 |
| Food and Beverage | $642.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,073.40 | 2021-2022 | |
| Medical Device Business Services, INC. | $1,666.07 | 2022-2023 | Matrixrib |
| Depuy Synthes Sales INC. | $210.80 | 2023 | Matrixrib |
| Conmed Corporation | $128.85 | 2023 | Airseal |
| Ethicon US, LLC | $103.31 | 2022-2024 | Harmonic, Echelon; Endopath, Echelon Endopath |
| Kerecis Limited | $78.63 | 2021-2022 | |
| Medtronic, INC. | $53.04 | 2021-2025 | Manoscan |
| Pacira Pharmaceuticals Incorporated | $40.48 | 2019-2023 | Exparel |
| Harrow Eye, LLC | $37.96 | 2025 | Iheezo |
| Boston Scientific Corporation | $33.52 | 2023 | |
| Lucid Diagnostics INC. | $26.37 | 2021-2023 | |
| Solventum Corporation | $25.05 | 2025 | Activ.A.C. |
| Braintree Laboratories, INC. | $24.10 | 2020-2021 | |
| Mallinckrodt Enterprises LLC | $18.62 | 2019 | |
| Merck Sharp & Dohme LLC | $13.04 | 2023 | Bridion |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Glatz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.